Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 6:24 pm Purchase |
2021-12-31 | 13G | SeaSpine Holdings Corporation SPNE |
Avidity Partners Management LP | 2,010,000 5.500% |
2,010,000 (New Position) |
Filing History |
| 2022-02-11 6:16 pm Purchase |
2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Avidity Partners Management LP | 1,896,000 6.000% |
1,896,000 (New Position) |
Filing History |
| 2022-02-11 6:07 pm Purchase |
2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
Avidity Partners Management LP | 1,849,538 5.200% |
1,849,538 (New Position) |
Filing History |
| 2022-02-01 3:33 pm Purchase |
2022-01-25 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 3,022,790 6.700% |
3,022,790 (New Position) |
Filing History |
| 2022-01-03 12:09 pm Purchase |
2021-12-30 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 322,820 6.600% |
322,820 (New Position) |
Filing History |
| 2022-01-03 12:07 pm Purchase |
2021-12-30 | 13G | Altimmune, Inc. ALT |
Avidity Partners Management LP | 2,765,000 7.000% |
2,765,000 (New Position) |
Filing History |
| 2021-12-01 11:04 am Purchase |
2021-11-30 | 13G | IDEAYA Biosciences, Inc. IDYA |
Avidity Partners Management LP | 2,470,179 6.400% |
2,470,179 (New Position) |
Filing History |
| 2021-10-27 6:12 pm Purchase |
2021-10-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Avidity Partners Management LP | 1,120,925 6.600% |
1,120,925 (New Position) |
Filing History |
| 2021-10-25 10:36 am Purchase |
2021-10-22 | 13G | IVERIC bio, Inc. ISEE |
Avidity Partners Management LP | 7,225,000 7.000% |
7,225,000 (New Position) |
Filing History |
| 2021-04-20 4:34 pm Purchase |
2021-04-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 4,750,000 9.900% |
1,442,000 (+43.59%) |
Filing History |
| 2021-03-22 4:05 pm Purchase |
2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Avidity Partners Management LP | 4,285,000 9.400% |
4,285,000 (New Position) |
Filing History |
| 2021-02-16 4:46 pm Purchase |
2020-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Avidity Partners Management LP | 1,470,390 6.200% |
132,977 (+9.94%) |
Filing History |
| 2021-02-16 12:01 pm Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
Avidity Partners Management LP | 731,000 5.100% |
731,000 (New Position) |
Filing History |
| 2021-02-16 11:43 am Purchase |
2020-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Avidity Partners Management LP | 1,979,800 9.900% |
882,546 (+80.43%) |
Filing History |
| 2021-02-16 11:38 am Purchase |
2020-12-31 | 13G | OncoSec Medical Incorporated ONCS |
Avidity Partners Management LP | 88,727 5.500% |
11,909 (+15.50%) |
Filing History |
| 2021-02-16 11:32 am Purchase |
2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 3,308,000 7.100% |
708,000 (+27.23%) |
Filing History |
| 2021-02-16 11:26 am Purchase |
2020-12-31 | 13G | Kadmon Holdings, Inc. KDMN |
Avidity Partners Management LP | 9,570,000 5.600% |
9,570,000 (New Position) |
Filing History |
| 2021-02-12 11:17 am Purchase |
2021-02-10 | 13G | Adicet Bio, Inc. ACET |
Avidity Partners Management LP | 1,860,000 9.500% |
1,860,000 (New Position) |
Filing History |
| 2021-02-01 6:10 pm Purchase |
2021-01-29 | 13G | Cardiff Oncology, Inc. CRDF |
Avidity Partners Management LP | 2,153,600 6.100% |
2,153,600 (New Position) |
Filing History |
| 2020-12-30 2:33 pm Purchase |
2020-12-29 | 13G | OncoSec Medical Incorporated ONCS |
Avidity Partners Management LP | 76,818 6.000% |
76,818 (New Position) |
Filing History |